Kai Pinkernell

Company: Glycostem Therapeutics

Job title: CMO

Seminars:

Off-the-Shelf NK Cells in European AML Clinical Trial 3:30 pm

Phase I/II a clinical trial in AML ongoing in the EU First outcomes at low doses Upcoming geographical and indication expansionRead more

day: Day One